Research reading room
Breast Invasive Carcinoma (TCGA, PanCancer Atlas)
Summary
Breast Invasive Carcinoma (TCGA, PanCancer Atlas) is a study catalogued by cBioPortal DataHub under the cancer-type code brca. EvidenceHelix groups it with breast studies and lists it in the TCGA PanCancer Atlas collection.
Study description
Breast Invasive Carcinoma TCGA PanCancer data. The original data is here (https://gdc.cancer.gov/about-data/publications/pancanatlas). The publications are here (https://www.cell.com/pb-assets/consortium/pancanceratlas/pancani3/index.html).
Text as published in the source's study metadata.
Citation & PubMed
TCGA, Cell 2018
Linked PubMed records: PMID 29625048, PMID 29596782, PMID 29622463, PMID 29617662, PMID 29625055, PMID 29625050, PMID 29617662, PMID 30643250, PMID 32214244, PMID 29625049, PMID 29850653, PMID 36334560
Source & licence
Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.
Source metadata
- Study identifier
- brca_tcga_pan_can_atlas_2018
- Short name
- Breast Invasive Carcinoma Breast (TCGA PanCan 2018)
- Source cancer-type code
- brca
- Reference genome
- not given
- Source access groups
- PUBLIC;PANCAN
- Original study
- View on cBioPortal
- Metadata file
- meta_study.txt at e1b75cd25b
- Database licence
- ODC Open Database License (ODbL) 1.0
Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data. TCGA data are available under the Broad Institute GDAC TCGA Analysis Pipeline License; TCGA-derived records are preliminary or legacy releases.
Citations
TCGA, Cell 2018
- PubMed record 29625048 ↗
- PubMed record 29596782 ↗
- PubMed record 29622463 ↗
- PubMed record 29617662 ↗
- PubMed record 29625055 ↗
- PubMed record 29625050 ↗
- PubMed record 29617662 ↗
- PubMed record 30643250 ↗
- PubMed record 32214244 ↗
- PubMed record 29625049 ↗
- PubMed record 29850653 ↗
- PubMed record 36334560 ↗
Citation counts are not part of the source metadata and are not shown.
Related studies
-
Breast Cancer (HTAN, 2022)
An omic and multidimensional spatial (OMS) atlas generated from four serial biopsies of an individual with metastatic breast cancer during 3.5 years of therapy. This resource links detailed, longitudinal clinical meta…
BreastOther published and consortium studiesSource code brcaPubMed 1 -
Breast Cancer (METABRIC, Nature 2012 & Nat Commun 2016)
Targeted sequencing of 2509 primary breast tumors with 548 matched normals.
BreastOther published and consortium studiesSource code brcaPubMed 3 -
Breast Cancer (MSK, Clinical Cancer Res 2020)
Whole-exome and MSK-IMPACT sequencing of 60 tumor/normal matched samples.
BreastMSK studiesSource code brcaPubMed 1 -
Breast Cancer (MSK, NPJ Breast Cancer 2019)
Targeted Sequencing of buparlisib + letrozole and alpelisib + letrozole-treated metastatic ER+ unmatched breast tumors.
BreastMSK studiesSource code brcaPubMed 1 -
Breast Cancer (SMC 2018)
Whole-exome sequencing of 187 primary tumors from a Korean breast cancer cohort (SMC).
BreastOther published and consortium studiesSource code brcaPubMed 1 -
Breast Cancer Xenografts (British Columbia, Nature 2015)
Whole genome/targeted sequencing to evaluate the clonal dynamics in 116 breast cancer patient xenografts.
BreastOther published and consortium studiesSource code brcaPubMed 1 -
Breast Invasive Carcinoma (British Columbia, Nature 2012)
Whole genome/exome sequencing analysis of 65 breast cancer samples
BreastOther published and consortium studiesSource code brcaPubMed 1 -
Breast Invasive Carcinoma (Broad, Nature 2012)
Whole-exome sequencing of 103 breast cancer tumor/normal sample pairs. Generated by the Broad Institute.
BreastOther published and consortium studiesSource code brcaPubMed 1